Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
333.5 USD | +0.55% | +1.42% | +23.22% |
Mar. 28 | Wells Fargo Raises Price Target on HCA Healthcare to $315 From $303, Maintains Equalweight Rating | MT |
Mar. 28 | Ondine Biomedical appoints new interim chief financial officer | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.22% | 88.22B | |
+1.01% | 100B | |
+10.42% | 29.28B | |
-3.88% | 18.37B | |
-3.46% | 14.74B | |
+19.69% | 12.27B | |
+0.17% | 12.26B | |
+31.78% | 12.11B | |
-32.28% | 11.68B | |
-12.00% | 11.41B |
- Stock
- Equities
- Stock HCA Healthcare, Inc. - Nyse
- News HCA Healthcare, Inc.
- Credit Suisse Lowers HCA Healthcare's Price Target to $260 from $296 After Lower-than-Consensus Q1 Adjusts EBITDA, Keeps Outperform Rating